CREDIT SUISSE AG/ - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 43 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$1,520,000
-6.2%
1,500,0000.0%0.00%0.0%
Q4 2020$1,621,000
-12.8%
1,500,000
-16.7%
0.00%0.0%
Q3 2020$1,860,000
-6.3%
1,800,0000.0%0.00%0.0%
Q2 2020$1,985,000
+8.9%
1,800,0000.0%0.00%
-50.0%
Q1 2020$1,822,000
-26.8%
1,800,000
-17.2%
0.00%0.0%
Q4 2019$2,488,000
-44.4%
2,175,000
-44.6%
0.00%
-50.0%
Q3 2019$4,477,000
+10.5%
3,925,000
+14.6%
0.00%0.0%
Q2 2019$4,051,000
-29.5%
3,425,000
-19.4%
0.00%
-20.0%
Q1 2019$5,745,000
+114.8%
4,250,000
+70.0%
0.01%
+66.7%
Q4 2018$2,675,000
+15.8%
2,500,000
+13.6%
0.00%
+50.0%
Q3 2018$2,310,000
+6.9%
2,200,0000.0%0.00%0.0%
Q2 2018$2,161,000
-66.9%
2,200,000
-66.7%
0.00%
-66.7%
Q1 2018$6,520,000
-18.4%
6,600,000
-12.8%
0.01%
-14.3%
Q4 2017$7,992,000
+82.8%
7,570,000
+82.9%
0.01%
+75.0%
Q3 2017$4,373,000
+19.4%
4,140,000
+19.8%
0.00%0.0%
Q2 2017$3,664,000
+62.1%
3,455,000
+47.1%
0.00%
+100.0%
Q1 2017$2,261,000
+103.9%
2,348,000
+113.5%
0.00%
+100.0%
Q4 2016$1,109,000
-91.3%
1,100,000
-91.9%
0.00%
-91.7%
Q3 2016$12,685,000
+797.1%
13,630,000
+581.5%
0.01%
+500.0%
Q2 2016$1,414,000
-22.3%
2,000,0000.0%0.00%0.0%
Q1 2016$1,820,000
-81.5%
2,000,000
-77.1%
0.00%
-81.8%
Q4 2015$9,813,0008,723,0000.01%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q3 2020
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders